Product Information
TYENNE 162 MG/0.9 ML AUTOINJCT is a brand biologic product labeled by Fresenius Kabi USA, LLC, priced at $820.6574 per ML under NDC 65219058401. Its NADAC has been published 45 times since Aug 20, 2025.
Strength
162 mg/.9mL
Manufacturer
Fresenius Kabi USA, LLCNDC
65219058401
Classification
Brand Biologic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
TOCILIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761275On Market Since
7/1/2024
Pharmacological Classes
Price Statistics
The NADAC for TYENNE 162 MG/0.9 ML AUTOINJCT has been published 45 times since Aug 20, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $820.6574 per ML |
|---|---|
| All-time high | $821.7093 (May 13, 2026) |
| All-time low | $819.6321 (May 20, 2026) |
| 52-week high | $821.7093 |
| 52-week low | $819.6321 |
| Median price | $819.7444 |
| Average price | $820.1680 |
| Largest weekly change | -0.3% (May 20, 2026) |
| Weeks tracked | 45 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TYENNE 162 MG/0.9 ML AUTOINJCT?
The current National Average Drug Acquisition Cost (NADAC) for TYENNE 162 MG/0.9 ML AUTOINJCT, manufactured by Fresenius Kabi USA, LLC, is $820.6574 per ML (NDC 65219058401), effective Jun 24, 2026.
How has the price of TYENNE 162 MG/0.9 ML AUTOINJCT changed over time?
Over the history we have for it, the NADAC for TYENNE 162 MG/0.9 ML AUTOINJCT has held within roughly two percent of its current level. It has been tracked across 45 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for TYENNE 162 MG/0.9 ML AUTOINJCT?
Since Aug 20, 2025, the NADAC for TYENNE 162 MG/0.9 ML AUTOINJCT has ranged from a low of $819.6321 (May 20, 2026) to a high of $821.7093 (May 13, 2026), with a median of $819.7444 per ML.
Are there cheaper alternatives to TYENNE 162 MG/0.9 ML AUTOINJCT?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TYENNE 162 MG/0.9 ML AUTOINJCT, but none are currently priced below it.
Who manufactures TYENNE 162 MG/0.9 ML AUTOINJCT?
TYENNE 162 MG/0.9 ML AUTOINJCT (NDC 65219058401) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a brand biologic product.
Related Drugs
Same classification